Skip to content

Cognitive Behavioural Therapy-Informed Groups for Psychosis

Cognitive Behavioural Therapy-Informed Groups for Psychosis

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05584215
Acronym
CBTp
Enrollment
0
Registered
2022-10-18
Start date
2023-06-03
Completion date
2024-01-02
Last updated
2024-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychosis

Keywords

cognitive behavioral therapy

Brief summary

This is a feasibility study of cognitive behavioural therapy-informed groups for psychiatric inpatients with positive symptoms of psychosis.

Detailed description

The majority of inpatients at Parkwood Institute Mental Health have symptoms of psychosis. In line with Health Quality Ontario standards for the treatment of psychosis, the investigators would like to implement and evaluate cognitive behavioural therapy for psychosis (CBTp) informed groups. The feasibility, acceptability, and preliminary efficacy of CBTp groups for inpatients will be examined. Pragmatically, the investigators propose to undergo training in CBTp, implement empirically-supported CBTp protocols developed for inpatients, track outcomes, and publish our findings. The investigators would also incorporate patient feedback to improve future iterations of the protocol. Such an undertaking would build research capacity in front line staff by encouraging engagement in CBTp group training, survey design, participant screening, data collection, analyses, and dissemination of findings.

Interventions

BEHAVIORALCognitive Behavioural Therapy for Psychosis Groups

Groups based on cognitive behavioural therapy for psychosis

Sponsors

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Can read/write in English * Has positive symptoms of psychosis that are distressing to them

Exclusion criteria

* Inability to tolerate group participation

Design outcomes

Primary

MeasureTime frameDescription
Clinical Outcomes in Routine Evaluation 10 (CORE-10)Up to 2 monthsThe Clinical Outcomes in Routine Evaluation 10 is a short 10 item easy-to-use assessment measure for common presentations of psychological distress, designed to be used for screening as well as over the course of treatment to track progress. The minimum value is 0, the maximum value is 40, and higher scores indicate a worse outcome.
Process of Recovery Questionnaire (QPR)Up to 2 monthsThe Process of Recovery Questionnaire is a 15 item questionnaire which was co-produced by people who experience psychosis and their accounts of recovery. The minimum value is 0, the maximum value is 60, and higher scores indicate a better outcome.

Secondary

MeasureTime frameDescription
The Positive and Negative Syndrome Scale (PANSS) - Positive SymptomsUp to 2 monthsA brief measure of positive symptoms of psychosis. The minimum value is 7, the maximum values is 49. Higher scores indicate a worse outcome.

Other

MeasureTime frameDescription
Satisfaction QuestionnaireUp to 2 monthsBrief open-ended questions about program satisfaction. Responses are qualitative.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026